You searched for "nAMD"
21st century cataract surgery training - a global perspective & cybersight @ 100% Ophthalmology
@15:15 – 16:15 Orbis’s online training and mentorship service for eye health professionals in developing countries.Research is everyone’s business @ 100% Ophthalmology
@16:15 – 17:00 The NHS Constitution pledges to inform patients of research studies in which they may be eligible to participate. The NHS Long Term Plan states that research will play a key part in improving the quality of patient care and health outcomes. The various professional regulatory bodies have mandated that registrants demonstrate an understanding of research, ethics and governance in order to apply research findings and inform best practice. Therefore, all staff working in health and social care are required to have an awareness of research as pertains to their practice. This session will explore how staff can incorporate research into their practice to make it business as usual.Independent Opticians Win SightCare Excellence Awards at the 2022 SightCare Business & Networking Conference
Six deserving independent optical practices were named as winners in the 2022 SightCare Awards celebrating the independent spirit.inserts
Eye News April/May 2022Real world data of post-IVT endophthalmitis, from a nurse-delivered intravitreal injection service
Introduction Intravitreal injection of neutralising anti-vascular endothelial growth factor (VEGF) antibody was licenced more than a decade ago, and over the years there has been proportionate increase in the number of intravitreal injections [1]. Injection of a therapeutic agent through...Celebrating eight years of the nurse-led intravitreal injection service
Moorfields Eye Hospital NHS Foundation Trust in London celebrated the eighth year of its nurse-led intravitreal (IVT) injection service in 2020. In collaboration with Beaver-Visitec International (BVI), Moorfields’ comprehensive one-day course for non-medical staff has blossomed into a thriving success....
Age-related macular degeneration
This review article offers an up to date review of the genetic and environmental risk factors associated with aetiology surrounding age-related macular degeneration (AMD). The article briefly describes the typical clinical presentation relating to early and late stages of the...
Four year outcomes of macular degeneration treated with ranibizumab
The authors report on a retrospective study of neovascular age-related macular degeneration (AMD) patients treated with a variable ranibizumab dosing regimen over a period of four years (from January 2007 to December 2011). A total of 600 treatment naïve eyes...Pegcetacoplan: A breakthrough treatment for dry age-related macular degeneration?
Age-related macular degeneration (AMD) is a degenerative condition affecting the macula, the part of the retina responsible for central vision. It is characterised by the presence of drusen and retinal pigment epithelium (RPE) abnormalities in the absence of other macular...
Features of AMD treatment non-responders
This is a retrospective consecutive case series of 365 eyes with age-related macular degeneration (AMD) who had three monthly intravitreal aflibercept treatments for at least 12 months. Responders were defined as complete resolution of exudation, intraretinal oedema, subretinal fluid, pigment...
Characteristics of Charles Bonnet syndrome in patients with neovascular AMD
This retrospective cross-sectional study aimed to characterise various aspects of Charles Bonnet syndrome hallucinations among patients with neovascular age-related macular degeneration (AMD). Five hundred and ten consecutive patients were asked a screening question to determine if they had ever suffered...
